updated data on ibrutinib therapy
Published 7 years ago • 60 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
4:48
updated data on ibrutinib for treatment of non-hodgkin lymphoma
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
25:38
cll: chemotherapy and ibrutinib based regimens
-
1:43
the latest ibrutinib data for treating cll
-
6:05
real-world data on the effect of ibrutinib flexible dosing treatment strategies on ttnt in cll/sll
-
1:33
dr. zelenetz on treatment for patients with cll who fail on ibrutinib or idelalisib
-
3:39
long-term efficacy and safety with ibrutinib in cll
-
3:15
long-term outcomes with ibrutinib
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
29:14
ibrutinib resistance-mechanisms and options in cll
-
1:56
ibrutinib plus venetoclax for first-line treatment of cll: 4-year follow-up data
-
4:40
mcl: long-term safety/efficacy data with ibrutinib
-
2:00
nivolumab combined with ibrutinib for cll, richter transformation
-
1:07
ibrutinib plus venetoclax as a treatment option for cll
-
0:51
dr. seymour on role of ibrutinib in cll
-
1:17
dose reductions to manage aes of ibrutinib treatment for cll
-
1:20
dr. byrd provides an update on ibrutinib in cll
-
1:55
dr. barr on updated resonate data in ighv-mutant cll
-
24:09
update on venetoclax for cll